Trials of sickle cell anemia treatments underway

06/17/2013 | San Diego Union-Tribune

Recruitment has begun for a midstage clinical trial to find out whether heart disease drug Lexiscan can alleviate attacks of sickle cell anemia. The NIH-supported study will test whether the drug can relieve pain and inflammation. Meanwhile, HemaQuest has completed the recruitment of patients with sickle cell disease for a Phase IIb study involving HQK-1001, which promotes the production of fetal hemoglobin.

View Full Article in:

San Diego Union-Tribune

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Active Implantable Medical Device (AIMD) Product Expert
BSI
Nationwide, SL_Nationwide
Finance Manager - ENT
Medtronic
Jacksonville, FL
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA